MK-677 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue. MK-677 is not fda-approved. not a controlled substance but banned by wada and dod. sold as research chemical.
What Does the Research Say About MK-677?
30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
MK-677 (Ibutamoren Mesylate) is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Research interest has focused on its potential effects on oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
What Is the Evidence for MK-677's Mechanism?
Selective non-peptide agonist of the ghrelin receptor (GHS-R1a) that increases GHRH production while simultaneously reducing somatostatin (GH inhibitor). Increases GH pulse amplitude and frequency, producing sustained IGF-1 elevation through enhanced endogenous GH secretion. Uniquely oral bioavailable with ~24-hour half-life enabling once-daily dosing.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for MK-677?
30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, MK-677 has shown encouraging results.
What Does the Safety Research Show?
Increased appetite (primary side effect), water retention, lethargy, joint pain, elevated prolactin. Insulin resistance with long-term use — monitor fasting glucose. Carpal tunnel syndrome reported at higher doses. Generally well-tolerated but requires metabolic monitoring.
MK-677 is not fda-approved. not a controlled substance but banned by wada and dod. sold as research chemical.
What Makes MK-677 Unique in Research?
The only oral GH secretagogue producing clinically significant GH elevation without injections — uniquely accessible and practical compared to every other peptide that requires subcutaneous administration.
This differentiator is important because it means MK-677 fills a role that other compounds in its class may not fully replicate.
Bottom Line on MK-677 Research
The evidence base for MK-677 is growing. Key research areas include oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
Stay current with PubMed searches for MK-677 for the latest publications.
Complete Guide
MK-677 (Ibutamoren): The Oral GH Secretagogue
Related Reading
- MK-677 Dosage Guide
- MK-677 Benefits
- MK-677 Side Effects
- MK-677 Stacking Guide
- MK-677 Cycle Guide
- BPC-157 Complete Guide
Calculate Your MK-677 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MK-677.
Open Calculator →Research-Grade Sourcing
If you're going to research MK-677, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MK-677?
MK-677 (Ibutamoren Mesylate) is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Synthetic non-peptide compound developed by Merck as an oral GH secretagogue alternative to injectable GHRPs. It is researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
What is the recommended MK-677 dosage?
Common dosages: 10-25 mg daily administered once daily (usually before bed) via oral. Cycle length: 8-16 weeks; minimum 10-week break between cycles. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of MK-677?
Increased appetite (primary side effect), water retention, lethargy, joint pain, elevated prolactin. Insulin resistance with long-term use — monitor fasting glucose. Carpal tunnel syndrome reported at higher doses. Generally well-tolerated but requires metabolic monitoring.
Is MK-677 safe?
MK-677 has shown a favorable safety profile in research. Not FDA-approved. Not a controlled substance but banned by WADA and DoD. Sold as research chemical. All research should follow appropriate safety protocols.